These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 299938)

  • 1. Methotrexate and azathioprine treatment of childhood dermatomyositis.
    Jacobs JC
    Pediatrics; 1977 Feb; 59(2):212-8. PubMed ID: 299938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rituximab as therapy for refractory polymyositis and dermatomyositis.
    Noss EH; Hausner-Sypek DL; Weinblatt ME
    J Rheumatol; 2006 May; 33(5):1021-6. PubMed ID: 16541475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of dermatomyositis.
    Jacobs JC
    Arthritis Rheum; 1977 Mar; 20(2 Suppl):338-41. PubMed ID: 263910
    [No Abstract]   [Full Text] [Related]  

  • 4. Dermatomyositis.
    Lever WF
    Arch Dermatol; 1972 May; 105(5):771-2. PubMed ID: 5026692
    [No Abstract]   [Full Text] [Related]  

  • 5. [Dermatomyositis in children: clinical course of 9 cases].
    García Consuegra J; Antelo MC; Torreblanca J
    An Esp Pediatr; 1987 Nov; 27(5):362-6. PubMed ID: 3439658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term maintenance treatment of moderate-to-severe plaque psoriasis with infliximab in combination with methotrexate or azathioprine in a retrospective cohort.
    Dalaker M; Bonesrønning JH
    J Eur Acad Dermatol Venereol; 2009 Mar; 23(3):277-82. PubMed ID: 19207642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of polymyositis and dermatomyositis.
    Kaye SA; Isenberg DA
    Br J Hosp Med; 1994 Nov 2-15; 52(9):463-8. PubMed ID: 7874361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of polymyositis and dermatomyositis.
    Ansell BM
    Clin Rheum Dis; 1984 Apr; 10(1):205-13. PubMed ID: 6734117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of survival in a cohort of patients with polymyositis and dermatomyositis: effect of corticosteroids, methotrexate and azathioprine.
    Schiopu E; Phillips K; MacDonald PM; Crofford LJ; Somers EC
    Arthritis Res Ther; 2012 Jan; 14(1):R22. PubMed ID: 22284862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Dermatomyositis and polymyositis: clinical aspects and treatment].
    Hachulla E
    Ann Med Interne (Paris); 2001 Nov; 152(7):455-64. PubMed ID: 11965087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low-dose methotrexate administered weekly is an effective corticosteroid-sparing agent for the treatment of the cutaneous manifestations of dermatomyositis.
    Kasteler JS; Callen JP
    J Am Acad Dermatol; 1997 Jan; 36(1):67-71. PubMed ID: 8996263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Therapeutic strategies in idiopatic inflammatory myopathies].
    Chakour R; Leimgruber A; Bart PA; Spertini F
    Rev Med Suisse; 2009 Apr; 5(199):812-8. PubMed ID: 19441746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kaposi's sarcoma in a patient with dermatomyositis receiving immunosuppressive therapy.
    Weiss VC; Serushan M
    Arch Dermatol; 1982 Mar; 118(3):183-5. PubMed ID: 7065668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination antimalarials in the treatment of cutaneous dermatomyositis: a retrospective study.
    Ang GC; Werth VP
    Arch Dermatol; 2005 Jul; 141(7):855-9. PubMed ID: 16027300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leflunomide as adjuvant treatment of dermatomyositis.
    Boswell JS; Costner MI
    J Am Acad Dermatol; 2008 Mar; 58(3):403-6. PubMed ID: 18194823
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of non-life threatening Wegener's granulomatosis with methotrexate and daily prednisone as the initial therapy of choice.
    Stone JH; Tun W; Hellman DB
    J Rheumatol; 1999 May; 26(5):1134-9. PubMed ID: 10332980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment of progressive and severe forms of multiple sclerosis using a combination of antilymphocyte serum, azathioprine and prednisone. Clinical and biological results. Comparison with a control group treated with azathioprine and prednisone only. 4-year follow-up].
    Lhermitte F; Marteau R; de Saxcé H
    Rev Neurol (Paris); 1987; 143(2):98-107. PubMed ID: 3299618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Polymyositis and dermatomyositis in childhood].
    Rodríguez Núñez A; Fernández Bustillo JM; Rodríguez Pérez E; Novo Rodríguez I; Pérez Becerra E; Peña Guitián J; Castro Gago M
    An Esp Pediatr; 1988 Oct; 29(4):288-92. PubMed ID: 3069018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methotrexate as rescue/adjunctive immunotherapy in infant and adult heart transplantation.
    Bouchart F; Gundry SR; Van Schaack-Gonzales J; Razzouk AJ; Marsa RJ; Kawauchi M; de Begona JA; Bailey LL
    J Heart Lung Transplant; 1993; 12(3):427-33. PubMed ID: 8329413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The PRINTO evidence-based proposal for glucocorticoids tapering/discontinuation in new onset juvenile dermatomyositis patients.
    Giancane G; Lavarello C; Pistorio A; Oliveira SK; Zulian F; Cuttica R; Fischbach M; Magnusson B; Pastore S; Marini R; Martino S; Pagnier A; Soler C; Staņēvicha V; Ten Cate R; Uziel Y; Vojinovic J; Fueri E; Ravelli A; Martini A; Ruperto N;
    Pediatr Rheumatol Online J; 2019 May; 17(1):24. PubMed ID: 31118099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.